johnson & johnson - Search News

Johnson & Johnson halts late-stage E.coli vaccine trial

Johnson & Johnson halts late-stage E.coli vaccine trial after poor results

Johnson & Johnson and Sanofi said that while the vaccine showed no safety concerns, it did not meet the necessary effectiveness thresholds.

Reuters on MSN · 2d

J&J, Sanofi stop E.coli vaccine trial due to low effectiveness

Johnson & Johnson and partner Sanofi will stop a late-stage trial of an experimental vaccine to prevent infections caused by the E.coli bacteria due to a lack of sufficient efficacy, the companies said on Thursday.

GlobalData on MSN · 2d

J&J stops Phase III trial of Sanofi’s E. Coli vaccine citing ‘disappointing’ results

The company said it will stop the Phase III trial of ExPEC after interim results found it failed to demonstrate efficacy over placebo.

An angry Johnson Wagner pops off at Rory McIlroy

Golfweek on MSN · 1d

An angry Johnson Wagner pops off at Rory McIlroy after recent comments

Rory McIlroy's comments that players should "get over" their hard feelings about reunifying men's pro golf didn't sit well with GC's Johnson Wagner.

Hosted on MSN · 20h

Johnson Wagner rebukes Rory McIlroy over LIV-PGA Tour comments: ‘He’s angering me right now’

During a Golf Channel segment, the three-time PGA Tour winner turned analyst rebuked Rory McIlroy for his recent comments regarding the tour and LIV Golf. During his press confere

Golf Monthly on MSN · 1d

'I’m A Huge Fan Of Rory But He Is Angering Me’ - Johnson Wagner Critical Of McIlroy’s 'Get Over It' Comments

Johnson Wagner was angered by Rory McIlroy's latest "get over it" comments, and feels the Northern Irishman is "trying to get his way in every way" in how the future of men's pro golf looks

10hon MSN

Johnson & Johnson to resume U.S. Varipulse cases after safety review

Johnson & Johnson (JNJ) stock in focus as limited rollout of Varipulse heart device resumes after a safety review prompted by ...

AOL13d

Is Johnson & Johnson Stock a Buy?

Johnson & Johnson (NYSE: JNJ) is one of the world's largest and most prominent healthcare leaders. If investing in a company came down to size, the stock would be a no-brainer buy. However ...

Johnson & Johnson (JNJ) Plans $1 Billion Sale of ‘Cerenovus’ Stroke Unit

Pharmaceutical giant Johnson & Johnson (JNJ) is planning to sell its stroke care business called “Cerenovus” for $1 billion ...

2don MSN

Johnson & Johnson reports progress on nipocalimab

HOUSE, Pa. - Johnson & Johnson (NYSE: NYSE:JNJ) has released new data on nipocalimab, an investigational drug with potential to treat diseases driven by immunoglobulin G (IgG) antibodies. Published in ...